Fei Xiao

Title: Fei Xiao: Innovator in Pharmaceutical Chemistry

Introduction

Fei Xiao is a prominent inventor based in Shanghai, China, known for his contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, he has secured two patents that highlight his expertise in the field.

Latest Patents

One of Fei Xiao's latest patents is titled "Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors." This invention provides a method for preparing a pyrrolopyrimidine compound and its application as an immunosuppressive drug. The patent details a compound represented by a specific formula and includes pharmaceutically-acceptable salts, along with a pharmaceutical composition containing the compound.

Another significant patent is for a "Triptolide derivative and preparation method therefor and use thereof." This patent describes a triptolide derivative with improved immunosuppressive and anti-tumor activity, characterized by low toxicity and high safety. The invention outlines the preparation method and potential applications of the triptolide derivative, indicating promising development prospects.

Career Highlights

Fei Xiao has worked with notable companies in the pharmaceutical sector, including Cinkate Pharmaceutical Intermediates Co., Ltd. and Cinakate Pharm Tech (Shanghai) Co., Ltd. His experience in these organizations has contributed to his innovative work in drug development.

Collaborations

Fei Xiao has collaborated with talented individuals in his field, including Na Liu and Lixia Bao. These partnerships have likely enhanced his research and development efforts.

Conclusion

Fei Xiao's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to advancing medical science. His innovative work continues to have a significant impact on the development of new therapeutic agents.